{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:37:39Z","timestamp":1787071059675,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Malignant peritoneal mesotheliomas (MPMs) are rare tumors with overlapping clinical and histopathological features, especially with epithelial ovarian carcinomas (EOCs). There is no substantial documentation on these rare tumors from our country.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To study the clinicopathological features including immunohistochemical (IHC) profile and clinical outcomes of 14 MPMs, diagnosed at our institution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This was a retrospective study, wherein 14 cases of MPM, occurring in female patients, diagnosed at our institution, between January 2008 and May 2019 were included, after a critical review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Median age was 54.5 years. Most patients presented with ascites, omental nodularity, and fat stranding. Microscopically, most cases (11, 78.6%) displayed epithelioid morphology, followed by biphasic pattern (2, 14.3%) and a single case of well-differentiated MPM. IHC, diagnostic sensitivity and specificity of calretinin were 100% (13\/13) and 85.7%; of HBME1 were 100% (5\/5) and 100%; and of podoplanin (D2\u201340) were 60% (2\/5) and 100%. Other positively expressed immunomarkers were epithelial membrane antigen (n = 2\/5, 40%), cytokeratin 5\/6 (n = 4\/4, 100%), and WT1 (n = 9\/10, 90%). Most patients (5\/12, 41.7%) were treated with chemotherapy. The 3-year disease-free and overall survival rates were 25.7% and 54%, respectively, including improved survival trend in patients with epithelioid type of MPMs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>MPMs are diagnosed with a combination of clinicopathological features and optimal IHC markers. Their differentiation from EOCs and other metastatic carcinomas is imperative in view of significant treatment implications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1292_20","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T08:02:54Z","timestamp":1637049774000},"page":"1683-1691","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Histopathological and immunohistochemical features of 14 peritoneal mesotheliomas with clinical outcomes and recent updates"],"prefix":"10.4103","volume":"18","author":[{"given":"Srushti","family":"Karmarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Rekhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedar K.","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-37-20241021","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdp307","article-title":"Malignant peritoneal mesothelioma: A multicenter study on 81 cases","volume":"21","author":"Manzini","year":"2010","journal-title":"Ann Oncol"},{"key":"R2-37-20241021","doi-asserted-by":"crossref","first-page":"915","DOI":"10.21037\/jgo.2017.08.01","article-title":"Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: A review","volume":"8","author":"Garc\u00eda-Fadrique","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"R3-37-20241021","first-page":"472","article-title":"Malignant peritoneal mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: Case series and review of the clinical and immunohistochemical features","volume":"5","author":"Ta\u015fk\u0131n","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"R4-37-20241021","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","article-title":"Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion","volume":"13","author":"Deraco","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R6-37-20241021","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/1097-0142(19900115)65:2<292::AID-CNCR2820650218>3.0.CO;2-W","article-title":"Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases","volume":"65","author":"Daya","year":"1990","journal-title":"Cancer"},{"key":"R7-37-20241021","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1309\/2H0NVRERPP2LJDUA","article-title":"Malignant peritoneal mesothelioma in women: A study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis","volume":"123","author":"Baker","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R8-37-20241021","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/dc.21248","article-title":"\u201cSignet-ring\u201d cells \u2013 A caveat in the diagnosis of a diffuse peritoneal mesothelioma occurring in a lady presenting with recurrent ascites: an unusual case report","volume":"38","author":"Rekhi","year":"2010","journal-title":"Diagn Cytopathol"},{"key":"R9-37-20241021","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/dc.21723","article-title":"Malignant biphasic peritoneal mesothelioma in a child: Fine-needle aspiration cytology, histopathology, and immunohistochemical features along with review of literature","volume":"40","author":"Arora","year":"2012","journal-title":"Diagn Cytopathol"},{"key":"R10-37-20241021","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4103\/0973-1482.139382","article-title":"A case report of peritoneal malignant mesothelioma presenting as primary ovarian mass","volume":"11","author":"Kapoor","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"R11-37-20241021","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijc.IJC_584_17","article-title":"Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India","volume":"55","author":"Hui","year":"2018","journal-title":"Indian J Cancer"},{"key":"R12-37-20241021","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X","article-title":"Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma","volume":"70","author":"Eltabbakh","year":"1999","journal-title":"J Surg Oncol"},{"key":"R13-37-20241021","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000478-199609000-00004","article-title":"Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas","volume":"20","author":"Clement","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R14-37-20241021","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.gore.2016.04.003","article-title":"A case of mesothelioma masquerading pre-operatively as ovarian cancer and brief review of the literature","volume":"17","author":"Hancock","year":"2016","journal-title":"Gynecol Oncol Rep"},{"key":"R15-37-20241021","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/modpathol.2012.105","article-title":"Deciduoid mesothelioma: Report of 21 cases with review of the literature","volume":"25","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Mod Pathol"},{"key":"R16-37-20241021","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2169\/internalmedicine.56.7791","article-title":"A rare case of biphasic malignant peritoneal mesothelioma with refractory ascites","volume":"56","author":"Komaki","year":"2017","journal-title":"Intern Med"},{"key":"R17-37-20241021","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1759-7714.12029","article-title":"Localized biphasic type malignant mesothelioma arising in the peritoneum: Report of a case","volume":"5","author":"Kohno","year":"2014","journal-title":"Thorac Cancer"},{"key":"R18-37-20241021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAS.0b013e3182354a79","article-title":"Well-differentiated papillary mesothelioma of the female peritoneum: A clinicopathologic study of 26 cases","volume":"36","author":"Malpica","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R19-37-20241021","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00000478-199810000-00005","article-title":"Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas","volume":"22","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R20-37-20241021","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jclinpath-2015-203211","article-title":"Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses","volume":"69","author":"Kawai","year":"2016","journal-title":"J Clin Pathol"},{"key":"R21-37-20241021","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1309\/8FCHQ3VPBWM7B5X9","article-title":"Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: Antibodies to estrogen and progesterone receptors are useful","volume":"125","author":"Barnetson","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R22-37-20241021","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/PAS.0b013e318033e7a8","article-title":"h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: A useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary","volume":"31","author":"Comin","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R23-37-20241021","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5858\/arpa.2017-0092-OA","article-title":"Immunohistochemistry in peritoneal mesothelioma: A single-center experience of 244 cases","volume":"142","author":"Tandon","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R24-37-20241021","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.MP.0000056981.16578.C3","article-title":"Value of mesothelin immunostaining in the diagnosis of mesothelioma","volume":"16","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Mod Pathol"},{"key":"R25-37-20241021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Chu","year":"2005","journal-title":"Mod Pathol"},{"key":"R26-37-20241021","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.humpath.2005.01.019","article-title":"D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma","volume":"36","author":"Ord\u00f3\u00f1ez","year":"2005","journal-title":"Hum Pathol"},{"key":"R27-37-20241021","first-page":"5871","article-title":"PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer","volume":"14","author":"Chai","year":"2017","journal-title":"Oncol Lett"},{"key":"R28-37-20241021","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/PGP.0000000000000309","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"36","author":"Laury","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R29-37-20241021","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R30-37-20241021","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00000478-200308000-00001","article-title":"The immunohistochemical diagnosis of mesothelioma: A comparative study of epithelioid mesothelioma and lung adenocarcinoma","volume":"27","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R31-37-20241021","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2559.2000.00770.x","article-title":"HBME-1, MOC-31, WT1 and calretinin: An assessment of recently described markers for mesothelioma and adenocarcinoma","volume":"36","author":"Oates","year":"2000","journal-title":"Histopathology"},{"key":"R32-37-20241021","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.5858\/2001-125-1316-IAONVC","article-title":"Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas","volume":"125","author":"Foster","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"R33-37-20241021","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R34-37-20241021","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"R35-37-20241021","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PAT.0b013e3283631cce","article-title":"Diffuse mesothelioma of the peritoneum: A pathological study of 64 tumours treated with cytoreductive therapy","volume":"45","author":"Lee","year":"2013","journal-title":"Pathology"},{"key":"R36-37-20241021","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<583::AID-CNCR22>3.0.CO;2-X","article-title":"The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses","volume":"82","author":"Wolanski","year":"1998","journal-title":"Cancer"},{"key":"R37-37-20241021","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2559.2006.02442.x","article-title":"Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: A systematic review of published reports","volume":"49","author":"King","year":"2006","journal-title":"Histopathology"},{"key":"R38-37-20241021","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","article-title":"New markers for separating benign from malignant mesothelial proliferations: Are we there yet?","volume":"140","author":"Churg","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"R39-37-20241021","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"R40-37-20241021","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.21037\/tlcr.2019.11.29","article-title":"Application of immunohistochemistry in diagnosis and management of malignant mesothelioma","volume":"9","author":"Chapel","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"R41-37-20241021","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12967-018-1559-7","article-title":"Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: Benefits to patient and family members","volume":"16","author":"Kittaneh","year":"2018","journal-title":"J Transl Med"},{"key":"R42-37-20241021","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tranon.2014.12.002","article-title":"Changing pattern in malignant mesothelioma survival","volume":"8","author":"Faig","year":"2015","journal-title":"Transl Oncol"},{"key":"R43-37-20241021","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAT.0000000000000181","article-title":"Diffuse mesothelioma of the peritoneum: Correlation between histological and clinical parameters and survival in 73 patients","volume":"46","author":"Liu","year":"2014","journal-title":"Pathology"},{"key":"R44-37-20241021","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/COC.0b013e3182a0e867","article-title":"Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma","volume":"38","author":"Pillai","year":"2015","journal-title":"Am J Clin Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1292_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:54Z","timestamp":1787067654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1292_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1292_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}